Sarah Borrell is currently the Head of Commercial-Immunology at Sanofi, having transitioned into this role in 2025 after serving as the Sales and Marketing Director for Immunology at Johnson & Johnson Innovative Medicine from 2022 to 2024. With extensive experience in the pharmaceutical and healthcare sectors, they previously held leadership positions at Novartis, where they managed the launch of the Cystic Fibrosis portfolio, and AstraZeneca, where they led the Oncology and Respiratory-Immunology Business Units. Sarah earned a Bachelor of Science degree in Human Evolution from the University of Liverpool from 1997 to 2001.
This person is not in the org chart
This person is not in any teams
This person is not in any offices